Income Taxes (Details) - USD ($) |
9 Months Ended | ||
|---|---|---|---|
Sep. 27, 2026 |
Sep. 28, 2025 |
Dec. 28, 2025 |
|
| Income Tax Disclosure [Abstract] | |||
| Effective tax rate (percent) | 25.40% | 23.60% | |
| Excess tax (benefits) deficiencies | $ (200,000) | $ (3,700,000) | |
| Increase or decrease to the valuation against deferred tax assets | 0 | 0 | |
| PAM, tax equity investment | 2,800,000 | $ 3,000,000.0 | |
| PAM, impairment loss | $ 0 | $ 0 | |
| X | ||||||||||
- Definition Amount of impairment loss for investment that generates income tax credit and other income tax benefit under tax credit program elected to be accounted for using proportional amortization method. Includes, but is not limited to, investment under tax credit program not meeting condition for accounting under proportional amortization method. Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef
|
| X | ||||||||||
- Definition Amount of investment that generates income tax credit and other income tax benefit under tax credit program elected to be accounted for using proportional amortization method. Includes, but is not limited to, investment under program not meeting condition for accounting under proportional amortization method. Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
|
| X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|